Ipca Laboratories Limited
IPCALAB
주식 순위
#3419
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
주가
$20.02
마지막 동기화: 2026-10-19
시가총액
$5.08B
변동 (1일)
-1.65%
변동 (1년)
37.56%
국가
IN
거래 Ipca Laboratories Limited (IPCALAB)
카테고리
Healthcare
Ipca Laboratories Limited (IPCALAB)의 매출
Jun 2026 기준 매출 TTM: $1.12B
Ipca Laboratories Limited의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $1.12B입니다. 2024년에 회사는 $924.15M의 수익을 올렸으며 이는 2023년의 $760.29M 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Ipca Laboratories Limited의 수익 기록 (2005 ~ 2026)
매년 말 매출
| 연도 | 매출 | 변화 |
|---|---|---|
| 2026 (TTM) | $1.12B | 6.89% |
| 2025 | $1.05B | 13.12% |
| 2024 | $924.15M | 21.55% |
| 2023 | $760.29M | -1.02% |
| 2022 | $768.09M | 3.73% |
| 2021 | $740.50M | 19.97% |
| 2020 | $617.22M | 13.54% |
| 2019 | $543.63M | 7.74% |
| 2018 | $504.56M | 3.67% |
| 2017 | $486.70M | 12.46% |
| 2016 | $432.77M | -14.12% |
| 2015 | $503.92M | -7.96% |
| 2014 | $547.51M | 5.75% |
| 2013 | $517.74M | 11.30% |
| 2012 | $465.16M | 9.12% |
| 2011 | $426.30M | 22.77% |
| 2010 | $347.24M | 37.32% |
| 2009 | $252.88M | -3.75% |
| 2008 | $262.72M | 21.27% |
| 2007 | $216.64M | 27.04% |
| 2006 | $170.53M | 9.66% |
| 2005 | $155.51M | 0.00% |
유사 기업 또는 경쟁사의 매출
| 회사 | 매출 | 매출 차이 | 국가 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 491.67% |
IN
|
